PA3-16736
antibody from Invitrogen Antibodies
Targeting: SSTR2
Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Immunocytochemistry [1]
- Immunohistochemistry [2]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA3-16736 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- SSTR2 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Reactivity
- Human, Mouse, Rat, Porcine
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µL
- Concentration
- Conc. Not Determined
- Storage
- -20°C or -80°C if preferred
Submitted references Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via inhibition of the NF-κB pathway.
Kim SE, Kim J, Lee JY, Lee SB, Paik JS, Yang SW
PloS one 2021;16(4):e0249988
PloS one 2021;16(4):e0249988
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunocytochemistry analysis of SSTR2 in U2OS cells fixed for 10 minutes using 10% formalin and then permeabilized for 5 minutes using 1X PBS + 0.05% Triton X-100. Samples were incubated in SSTR2 polyclonal antibody (Product # PA3-16736) using a dilution of 1:50 overnight at 4 °C followed by anti-rabbit DyLight 488 (Green) with a dilution of 1:500. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of SSTR2 in mouse pancreas. Samples were incubated in SSTR2 polyclonal antibody (Product # PA3-16736) followed by DAB with hematoxylin counterstain.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of SSTR2 in paraffin embedded rat pancreas tissue. Samples were incubated in SSTR2 polyclonal antibody (Product # PA3-16736).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Fig 3 OFs from patients with TAO expressed higher levels of somatostatin receptor type (SSTR) 2. (A) OFs were plated at a concentration of 2 x 10 5 cells/well in a 6-well plate. After 24 hours, the levels of SSTR2 on the cell surface of OFs from control individuals (#111, #116, #155) and patients with TAO (#135, #137, #162) were examined by flow cytometry. The gray open histogram represents staining with isotype control antibodies. (B) Mean fluorescence intensity of SSTR2 was 2.85-fold higher in patients with TAO compared to control individuals.